These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6630172

  • 61. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
    Rummel A, Mahrhold S, Bigalke H, Binz T.
    FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
    [Abstract] [Full Text] [Related]

  • 62. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813.
    Terajima J, Syuto B, Ochanda JO, Kubo S.
    Infect Immun; 1985 May; 48(2):312-7. PubMed ID: 3988338
    [Abstract] [Full Text] [Related]

  • 63. Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins types A and B.
    Ashton AC, Dolly JO.
    J Neurochem; 1991 Mar; 56(3):827-35. PubMed ID: 1847184
    [Abstract] [Full Text] [Related]

  • 64. Diagnostic and possible therapeutic application of a monoclonal antibody (14G8) directed against botulinum type C neurotoxin.
    Montgomery VA, Smith LA.
    Hybridoma (Larchmt); 2011 Jun; 30(3):209-16. PubMed ID: 21707354
    [Abstract] [Full Text] [Related]

  • 65. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N, Kamata Y, Simpson LL.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [Abstract] [Full Text] [Related]

  • 66. Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex.
    Otto H, Hanson PI, Chapman ER, Blasi J, Jahn R.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):945-52. PubMed ID: 7626135
    [Abstract] [Full Text] [Related]

  • 67. Botulinum toxin type A blocks the morphological changes induced by chemical stimulation on the presynaptic membrane of Torpedo synaptosomes.
    Marsal J, Egea G, Solsona C, Rabasseda X, Blasi J.
    Proc Natl Acad Sci U S A; 1989 Jan 26; 86(1):372-6. PubMed ID: 2463625
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
    Bakry N, Kamata Y, Sorensen R, Simpson LL.
    J Pharmacol Exp Ther; 1991 Aug 26; 258(2):613-9. PubMed ID: 1865360
    [Abstract] [Full Text] [Related]

  • 71. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.
    Kozaki S, Ogasawara J, Shimote Y, Kamata Y, Sakaguchi G.
    Infect Immun; 1987 Dec 26; 55(12):3051-6. PubMed ID: 2824382
    [Abstract] [Full Text] [Related]

  • 72. Ganglioside GD3 enhances adherence of botulinum and tetanus neurotoxins to bovine brain synapsin I.
    Schengrund CL, DasGupta BR, Ringler NJ.
    Neurosci Lett; 1993 Aug 20; 158(2):159-62. PubMed ID: 8233089
    [Abstract] [Full Text] [Related]

  • 73. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 74. Molecular basis of immunogenicity to botulinum neurotoxins and uses of the defined antigenic regions.
    Atassi MZ.
    Toxicon; 2015 Dec 01; 107(Pt A):50-8. PubMed ID: 26086358
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Detection of Clostridium tetani Neurotoxins Inhibited In Vivo by Botulinum Antitoxin B: Potential for Misleading Mouse Test Results in Food Controls.
    Bano L, Tonon E, Drigo I, Pirazzini M, Guolo A, Farina G, Agnoletti F, Montecucco C.
    Toxins (Basel); 2018 Jun 19; 10(6):. PubMed ID: 29921757
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Selective location of acceptors for botulinum neurotoxin A in the central and peripheral nervous systems.
    Black JD, Dolly JO.
    Neuroscience; 1987 Nov 19; 23(2):767-79. PubMed ID: 2830561
    [Abstract] [Full Text] [Related]

  • 79. Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B, and E: use of hapten-labeled-antibody elution to isolate specific complexes.
    Doellgast GJ, Brown JE, Koufman JA, Hatheway CL.
    J Clin Microbiol; 1997 Mar 19; 35(3):578-83. PubMed ID: 9041392
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.